{"id":"https://openalex.org/W4412872065","doi":"https://doi.org/10.3389/fbinf.2025.1580967","title":"Design of cross-reactive antigens with machine learning and high-throughput experimental evaluation","display_name":"Design of cross-reactive antigens with machine learning and high-throughput experimental evaluation","publication_year":2025,"publication_date":"2025-07-16","ids":{"openalex":"https://openalex.org/W4412872065","doi":"https://doi.org/10.3389/fbinf.2025.1580967","pmid":"https://pubmed.ncbi.nlm.nih.gov/40761757"},"language":"en","primary_location":{"id":"doi:10.3389/fbinf.2025.1580967","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fbinf.2025.1580967","pdf_url":null,"source":{"id":"https://openalex.org/S4210219554","display_name":"Frontiers in Bioinformatics","issn_l":"2673-7647","issn":["2673-7647"],"is_oa":true,"is_in_doaj":true,"is_core":true,"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioinformatics","raw_type":"journal-article"},"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fbinf.2025.1580967","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089671466","display_name":"Chelsy Chesterman","orcid":"https://orcid.org/0000-0003-2854-4547"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Chelsy Chesterman","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087606710","display_name":"Thomas Desautels","orcid":"https://orcid.org/0000-0001-6853-981X"},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Desautels","raw_affiliation_strings":["Lawrence Livermore National Laboratory, Livermore, CA, United States"],"affiliations":[{"raw_affiliation_string":"Lawrence Livermore National Laboratory, Livermore, CA, United States","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073484366","display_name":"L. F. Chaparro Sierra","orcid":"https://orcid.org/0000-0002-6570-9075"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Luz-Jeannette Sierra","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076617901","display_name":"Kathryn T. Arrildt","orcid":"https://orcid.org/0000-0001-6329-6214"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn T. Arrildt","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083445132","display_name":"Adam Zem\u0142a","orcid":"https://orcid.org/0000-0003-0504-8647"},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Zemla","raw_affiliation_strings":["Lawrence Livermore National Laboratory, Livermore, CA, United States"],"affiliations":[{"raw_affiliation_string":"Lawrence Livermore National Laboratory, Livermore, CA, United States","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016987266","display_name":"Edmond Y. Lau","orcid":"https://orcid.org/0000-0003-0619-7249"},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edmond Y. Lau","raw_affiliation_strings":["Lawrence Livermore National Laboratory, Livermore, CA, United States"],"affiliations":[{"raw_affiliation_string":"Lawrence Livermore National Laboratory, Livermore, CA, United States","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111191129","display_name":"Shivshankar Sundaram","orcid":"https://orcid.org/0000-0001-6675-6765"},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shivshankar Sundaram","raw_affiliation_strings":["Lawrence Livermore National Laboratory, Livermore, CA, United States"],"affiliations":[{"raw_affiliation_string":"Lawrence Livermore National Laboratory, Livermore, CA, United States","institution_ids":["https://openalex.org/I1282311441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058845824","display_name":"Jason P. Laliberte","orcid":"https://orcid.org/0009-0006-7131-1369"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason Laliberte","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026117007","display_name":"Lynn Chen","orcid":"https://orcid.org/0000-0002-2015-5638"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lynn Chen","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075674178","display_name":"Aaron Ruby","orcid":null},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Ruby","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5119173931","display_name":"Mark Mednikov","orcid":null},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Mednikov","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033128251","display_name":"Sylvie Bertholet","orcid":"https://orcid.org/0000-0002-1298-8859"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sylvie Bertholet","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018925795","display_name":"Dong Yu","orcid":"https://orcid.org/0000-0003-3406-972X"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dong Yu","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013239716","display_name":"Kate Luisi","orcid":"https://orcid.org/0000-0003-2945-8712"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kate Luisi","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008027591","display_name":"E. Malito","orcid":"https://orcid.org/0000-0002-1669-5607"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Enrico Malito","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091303440","display_name":"Corey P. Mallett","orcid":"https://orcid.org/0000-0002-6232-8111"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey P. Mallett","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058047069","display_name":"Matthew J. Bottomley","orcid":"https://orcid.org/0000-0001-9734-5694"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J. Bottomley","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058693463","display_name":"Robert A. Berg","orcid":"https://orcid.org/0000-0001-5529-9431"},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. van den Berg","raw_affiliation_strings":["GSK, Rockville, MD, United States"],"affiliations":[{"raw_affiliation_string":"GSK, Rockville, MD, United States","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087736344","display_name":"Daniel Faissol","orcid":"https://orcid.org/0000-0001-6965-983X"},"institutions":[{"id":"https://openalex.org/I1282311441","display_name":"Lawrence Livermore National Laboratory","ror":"https://ror.org/041nk4h53","country_code":"US","type":"facility","lineage":["https://openalex.org/I1282311441","https://openalex.org/I1330989302","https://openalex.org/I198811213","https://openalex.org/I4210138311"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Daniel Faissol","raw_affiliation_strings":["Lawrence Livermore National Laboratory, Livermore, CA, United States"],"affiliations":[{"raw_affiliation_string":"Lawrence Livermore National Laboratory, Livermore, CA, United States","institution_ids":["https://openalex.org/I1282311441"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":19,"corresponding_author_ids":["https://openalex.org/A5087736344","https://openalex.org/A5089671466"],"corresponding_institution_ids":["https://openalex.org/I1282311441","https://openalex.org/I4210114143"],"apc_list":{"value":1900,"currency":"USD","value_usd":1900},"apc_paid":{"value":1900,"currency":"USD","value_usd":1900},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.1657997,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":null,"first_page":"1580967","last_page":"1580967"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.9998000264167786,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.9998000264167786,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9995999932289124,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10873","display_name":"Bacterial Infections and Vaccines","score":0.9994000196456909,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epitope","display_name":"Epitope","score":0.8173125982284546},{"id":"https://openalex.org/keywords/antigen","display_name":"Antigen","score":0.6813732385635376},{"id":"https://openalex.org/keywords/computational-biology","display_name":"Computational biology","score":0.6033837795257568},{"id":"https://openalex.org/keywords/mutant","display_name":"Mutant","score":0.5219389796257019},{"id":"https://openalex.org/keywords/antigenicity","display_name":"Antigenicity","score":0.49709251523017883},{"id":"https://openalex.org/keywords/biology","display_name":"Biology","score":0.45447003841400146},{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.3757147490978241},{"id":"https://openalex.org/keywords/virology","display_name":"Virology","score":0.3220827281475067},{"id":"https://openalex.org/keywords/immunology","display_name":"Immunology","score":0.1986669898033142},{"id":"https://openalex.org/keywords/gene","display_name":"Gene","score":0.13663730025291443},{"id":"https://openalex.org/keywords/genetics","display_name":"Genetics","score":0.12297731637954712}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.8173125982284546},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6813732385635376},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.6033837795257568},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.5219389796257019},{"id":"https://openalex.org/C2779026604","wikidata":"https://www.wikidata.org/wiki/Q4774742","display_name":"Antigenicity","level":3,"score":0.49709251523017883},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.45447003841400146},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3757147490978241},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3220827281475067},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1986669898033142},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.13663730025291443},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.12297731637954712}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3389/fbinf.2025.1580967","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fbinf.2025.1580967","pdf_url":null,"source":{"id":"https://openalex.org/S4210219554","display_name":"Frontiers in Bioinformatics","issn_l":"2673-7647","issn":["2673-7647"],"is_oa":true,"is_in_doaj":true,"is_core":true,"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioinformatics","raw_type":"journal-article"},{"id":"pmid:40761757","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40761757","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in bioinformatics","raw_type":null},{"id":"pmh:oai:doaj.org/article:1b1c62e6a72d478cb54de275482d407e","is_oa":true,"landing_page_url":"https://doaj.org/article/1b1c62e6a72d478cb54de275482d407e","pdf_url":null,"source":{"id":"https://openalex.org/S112646816","display_name":"SHILAP Revista de lepidopterolog\u00eda","issn_l":"0300-5267","issn":["0300-5267","2340-4078"],"is_oa":true,"is_in_doaj":true,"is_core":false,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Bioinformatics, Vol 5 (2025)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/29608430","is_oa":true,"landing_page_url":null,"pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Figure"},{"id":"pmh:oai:pubmedcentral.nih.gov:12319226","is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12319226","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Front Bioinform","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3389/fbinf.2025.1580967","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fbinf.2025.1580967","pdf_url":null,"source":{"id":"https://openalex.org/S4210219554","display_name":"Frontiers in Bioinformatics","issn_l":"2673-7647","issn":["2673-7647"],"is_oa":true,"is_in_doaj":true,"is_core":true,"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Bioinformatics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7400000095367432}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":73,"referenced_works":["https://openalex.org/W1031578623","https://openalex.org/W1975355256","https://openalex.org/W1994891218","https://openalex.org/W1998949617","https://openalex.org/W2012763858","https://openalex.org/W2014159272","https://openalex.org/W2023490488","https://openalex.org/W2029875065","https://openalex.org/W2030543393","https://openalex.org/W2046452372","https://openalex.org/W2053940732","https://openalex.org/W2059359501","https://openalex.org/W2074610853","https://openalex.org/W2099201756","https://openalex.org/W2101058639","https://openalex.org/W2101695265","https://openalex.org/W2103459989","https://openalex.org/W2114335525","https://openalex.org/W2121688928","https://openalex.org/W2124026197","https://openalex.org/W2124672930","https://openalex.org/W2144370704","https://openalex.org/W2145317354","https://openalex.org/W2150453173","https://openalex.org/W2152360551","https://openalex.org/W2163341755","https://openalex.org/W2180229411","https://openalex.org/W2192203593","https://openalex.org/W2216045586","https://openalex.org/W2283896596","https://openalex.org/W2303048226","https://openalex.org/W2323929490","https://openalex.org/W2419025528","https://openalex.org/W2485730515","https://openalex.org/W2542266457","https://openalex.org/W2616619952","https://openalex.org/W2778717962","https://openalex.org/W2786497891","https://openalex.org/W2885204620","https://openalex.org/W2956569764","https://openalex.org/W2964307930","https://openalex.org/W2964965456","https://openalex.org/W2969229784","https://openalex.org/W2992586577","https://openalex.org/W2997591727","https://openalex.org/W3004483087","https://openalex.org/W3022788428","https://openalex.org/W3037163353","https://openalex.org/W3040508291","https://openalex.org/W3044914269","https://openalex.org/W3090364364","https://openalex.org/W3097190616","https://openalex.org/W3100511085","https://openalex.org/W3111255098","https://openalex.org/W3113734454","https://openalex.org/W3138783506","https://openalex.org/W3173444702","https://openalex.org/W3177500196","https://openalex.org/W4220757565","https://openalex.org/W4226032726","https://openalex.org/W4248872320","https://openalex.org/W4249066710","https://openalex.org/W4312197262","https://openalex.org/W4313892628","https://openalex.org/W4366823175","https://openalex.org/W4392968035","https://openalex.org/W4396721167","https://openalex.org/W4396732509","https://openalex.org/W4400482950","https://openalex.org/W6629804754","https://openalex.org/W6675354045","https://openalex.org/W6681821898","https://openalex.org/W6810389141"],"related_works":["https://openalex.org/W786416207","https://openalex.org/W2367852944","https://openalex.org/W2115812853","https://openalex.org/W2004255297","https://openalex.org/W2078727461","https://openalex.org/W2008472229","https://openalex.org/W2435839362","https://openalex.org/W2396550544","https://openalex.org/W2072925709","https://openalex.org/W2205639271"],"abstract_inverted_index":{"Selecting":[0],"an":[1,77],"optimal":[2],"antigen":[3,25,50,78,90,232],"is":[4],"a":[5,41,48,57,93,143,229],"crucial":[6],"step":[7],"in":[8,30,106],"vaccine":[9],"development,":[10],"significantly":[11],"influencing":[12],"both":[13,135,154],"the":[14,18,38,69,80,110,136,160,176,207,226,237],"vaccine's":[15],"effectiveness":[16],"and":[17,128,139,158,200],"breadth":[19],"of":[20,40,71,88,112,178,210,228,239],"protection":[21,54],"it":[22],"provides.":[23],"High":[24],"sequence":[26],"variability,":[27],"as":[28],"seen":[29],"pathogens":[31],"like":[32],"rhinovirus,":[33],"HIV,":[34],"influenza":[35],"virus,":[36],"complicates":[37],"design":[39,70,233],"single":[42,49,58],"cross-protective":[43],"antigen.":[44],"Consequently,":[45],"vaccination":[46],"with":[47],"molecule":[51],"often":[52],"confers":[53],"against":[55],"only":[56],"variant.":[59],"In":[60,167],"this":[61,215],"study,":[62],"machine":[63,113,129,161],"learning":[64,114,130,162],"methods":[65],"were":[66,150,172],"applied":[67,132],"to":[68,124,133,153,190,204],"factor":[72],"H":[73],"binding":[74,105,189],"protein":[75],"(fHbp),":[76],"from":[79],"bacterial":[81],"pathogen":[82],"<i>Neisseria":[83],"meningitidis</i>.":[84],"The":[85,194,219],"vast":[86],"number":[87],"potential":[89],"mutants":[91,141,149,171],"presents":[92],"significant":[94],"challenge":[95],"for":[96,164],"improving":[97],"fHbp":[98,126,179,185,211],"antigenicity.":[99],"Moreover,":[100],"limited":[101],"data":[102],"on":[103],"antigen-antibody":[104],"public":[107],"databases":[108],"constrains":[109],"training":[111],"models.":[115],"To":[116],"address":[117],"these":[118],"challenges,":[119],"we":[120],"used":[121],"computational":[122],"models":[123],"predict":[125],"properties":[127],"was":[131,212],"select":[134],"most":[137],"promising":[138,156],"informative":[140],"using":[142],"Gaussian":[144],"process":[145],"(GP)":[146],"model.":[147],"These":[148],"experimentally":[151],"evaluated":[152],"confirm":[155,205],"leads":[157],"refine":[159],"model":[163],"future":[165],"iterations.":[166],"our":[168],"current":[169],"model,":[170],"designed":[173],"that":[174,206],"enabled":[175],"transfer":[177],"v1.1":[180],"specific":[181],"conformational":[182],"epitopes":[183],"onto":[184],"v3.28,":[186],"while":[187],"maintaining":[188],"overlapping":[191],"cross-reactive":[192],"epitopes.":[193],"top":[195],"mutant":[196],"identified":[197],"underwent":[198],"biophysical":[199],"x-ray":[201],"crystallographic":[202],"characterization":[203],"overall":[208],"structure":[209],"maintained":[213],"throughout":[214],"epitope":[216],"engineering":[217],"experiment.":[218],"integrated":[220],"strategy":[221],"presented":[222],"here":[223],"could":[224],"form":[225],"basis":[227],"next-generation,":[230],"iterative":[231],"platform,":[234],"potentially":[235],"accelerating":[236],"development":[238],"new":[240],"broadly":[241],"protective":[242],"vaccines.":[243]},"counts_by_year":[],"updated_date":"2026-04-21T08:09:41.155169","created_date":"2025-10-10T00:00:00"}
